Congress has made renewal of the R&D Tax Credit a legislative priority, although several proposed changes are under consideration. We will discuss the changes to the credit after Congress advances the agenda and assess the political climate and likelihood for passage following the November mid-term elections. We also will provide an update on Section 48D Qualifying Therapeutic Discovery Project. Registration begins at 8 am, or find more information and online registration here.